Don't get left behind! The modernized ClinicalTrials.gov is coming. Check it out now.
Say goodbye to ClinicalTrials.gov!
The new site is coming soon - go to the modernized ClinicalTrials.gov
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Impact of Rituximab on MRI Evidence of Disease Activity in Patients With Moderate to Severe Rheumatoid Arthritis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT00425932
Recruitment Status : Completed
First Posted : January 24, 2007
Last Update Posted : August 22, 2013
Sponsor:
Collaborators:
Oklahoma Medical Research Foundation
Genentech, Inc.
Information provided by (Responsible Party):
Gaylis, Norman B., M.D.

Results Submitted - Not Posted on ClinicalTrials.gov
Results information has been submitted to ClinicalTrials.gov by the sponsor or investigator, but is not yet publicly available (or "posted") on ClinicalTrials.gov. The submitted information may not be available if it is pending Quality Control (QC) Review by the National Library of Medicine (NLM) or if issues identified during QC review are being addressed or corrected by the sponsor or investigator. NLM's limited QC review assesses for apparent errors, deficiencies, or inconsistencies. NLM staff do not verify the scientific validity or relevance of the submitted information.
Recruitment Status : Completed
Actual Primary Completion Date : November 2011
Actual Study Completion Date : November 2012
Submission Cycle Results Submitted to ClinicalTrials.gov Results Returned after Quality Control Review
1 May 22, 2018
 June 21, 2018
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):